Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials.

Subjects

Subjects :

Denosumab adverse effects
Diphosphonates
Humans
Randomized Controlled Trials as Topic
Bone Density Conservation Agents adverse effects
Neoplasms

Details

Language :

English

ISSN :

1433-2965

Volume :

32

Issue :

10

Database :

MEDLINE

Journal :

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Publication Type :

Editorial & Opinion

Accession number :

34383097

Full Text :

https://doi.org/10.1007/s00198-021-06033-y